1529-0131a/asset/cover.gif?v=1&s=4b71f39689e424fbb0e6725b1c033cc646a4272b "Arthritis Care & Research")
Dr. Ryan has received speaking fees (less than $10,000 each) from Wyeth, Servier, and Mundipharma.
2151-4658/asset/olbannerleft.gif?v=1&s=75d1dd4933b4687fdb365bb32190b0a4ef453ee7)
2151-4658/asset/olbannerright.gif?v=1&s=a36ba6af41bd9af370864f6461a516746a709d31)
Rheumatoid Arthritis
You have full text access to this OnlineOpen article
Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate
Article first published online: 30 MAY 2008
DOI: 10.1002/art.23716
Copyright © 2008 by the American College of Rheumatology
Additional Information
How to Cite
Buchbinder, R., Barber, M., Heuzenroeder, L., Wluka, A. E., Giles, G., Hall, S., Harkness, A., Lewis, D., Littlejohn, G., Miller, M. H., Ryan, P. F. J. and Jolley, D. (2008), Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate. Arthritis & Rheumatism, 59: 794–799. doi: 10.1002/art.23716
Publication History
- Issue published online: 30 MAY 2008
- Article first published online: 30 MAY 2008
- Manuscript Accepted: 10 DEC 2007
- Manuscript Received: 1 AUG 2007
Funded by
- Australian National Health and Medical Research Council Practitioner Fellowship
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , Melanoma and rheumatoid arthritis (brief report), Clinical Rheumatology, 2012, 31, 6, 1001
- 2, , , , , The use of methotrexate in dermatology: a review, Australasian Journal of Dermatology, 2012, 53, 1Direct Link:
- 3, , , , , , , , Integrated safety analysis: Short- and long-term safety profiles of etanercept in patients with psoriasis, Journal of the American Academy of Dermatology, 2011,
- 4, , , Malignant melanoma during treatment with fumaric acid esters – coincidence or treatment-related?, JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2011, 9, 3Direct Link:
- 5, , , , , Neuroendokrin daganat májmetasztázisainak teljes és tartós remissziója szomatosztatinanalóg-kezelés hatására, Orvosi Hetilap, 2011, 152, 10, 407
- 6, , , , , , Risk of non-melanoma skin cancer in a national cohort of veterans with rheumatoid arthritis, Rheumatology, 2011, 50, 8, 1431
- 7, , , , Rituximab dans la polyarthrite rhumatoïde et risque de cancer : résultats d’une cohorte française, Revue du Rhumatisme, 2011, 78, 5, 427
- 8, , , , Rituximab in rheumatoid arthritis and the risk of malignancies: Report from a French cohort, Joint Bone Spine, 2011, 78, 5, 484
- 9, , Roles of the immune system in skin cancer, British Journal of Dermatology, 2011, 165, 5Direct Link:
- 10, , , , The risk of cancer in patients with rheumatoid arthritis: A nationwide cohort study in Taiwan, Arthritis & Rheumatism, 2011, 63, 2Direct Link:
- 11
- 12
- 13, , , , , , Léiomyosarcome de la veine rénale gauche dans un contexte de polyarthrite rhumatoïde sous méthotrexate, Journal des Maladies Vasculaires, 2010, 35, 3, 194
- 14, , Update on the risk of lymphoma following immunosuppressive therapy for inflammatory bowel disease, Expert Review of Clinical Immunology, 2010, 6, 4, 621
- 15, , , , , , , , , , , , , , , , A series of critically challenging case scenarios in moderate to severe psoriasis: A Delphi consensus approach, Journal of the American Academy of Dermatology, 2009, 61, 1, S1
- 16
- 17, , , , , , , , , Ankylosing Spondylitis Patients Commencing Biologic Therapy Have High Baseline Levels of Comorbidity: A Report from the Australian Rheumatology Association Database, International Journal of Rheumatology, 2009, 2009, 1
- 18, , , , , , , , , , Baseline Comorbidities in a Population-Based Cohort of Rheumatoid Arthritis Patients Receiving Biological Therapy: Data from the Australian Rheumatology Association Database, International Journal of Rheumatology, 2009, 2009, 1
- 19, , , , , , , , Die Rationale für Knochenmarkuntersuchungen bei Patienten mit entzündlich-rheumatischen Erkrankungen, Wiener klinische Wochenschrift, 2009, 121, 21-22, 690
- 20, , , , Discussion: DMARDs and biologic therapies in the management of inflammatory joint diseases, Expert Review of Clinical Immunology, 2009, 5, 3, 291
- You have free access to this content21, , , General health maintenance in IBD, Inflammatory Bowel Diseases, 2009, 15, 9Direct Link:
- 22, , Is there truly a risk of lymphoma from biologic therapies?, Dermatologic Therapy, 2009, 22, 5Direct Link:
- 23, , , , Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference, Journal of the American Academy of Dermatology, 2009, 60, 5, 824
- 24, , , , , Oral methotrexate as adjunctive therapy in patients with multifocal motor neuropathy on chronic IVIg therapy, Journal of the Peripheral Nervous System, 2009, 14, 3Direct Link:
- 25, , , , Regression of advanced melanoma upon withdrawal of immunosuppression: case series and literature review, Medical Oncology, 2009, 27, 4, 1127
- 26, , , , Risk of cancer among rheumatoid arthritis patients in California, Cancer Causes & Control, 2009, 20, 6, 1001
- 27, , , , Treatments for psoriasis and the risk of malignancy, Journal of the American Academy of Dermatology, 2009, 60, 6, 1001
- 28, , Risk of skin cancer in the drug treatment of rheumatoid arthritis, Expert Opinion on Drug Safety, 2008, 7, 5, 539